<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04205461</url>
  </required_header>
  <id_info>
    <org_study_id>ParisCardioRC</org_study_id>
    <nct_id>NCT04205461</nct_id>
  </id_info>
  <brief_title>Prospective Evaluation of Programmed Ventricular Stimulation Before Pulmonary Valve Replacement in Patients With Tetralogy of Fallot</brief_title>
  <official_title>Prospective Evaluation of Programmed Ventricular Stimulation Before Pulmonary Valve Replacement in Patients With Tetralogy of Fallot</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Paris Cardiovascular Research Center (Inserm U970)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>European Georges Pompidou Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre Chirurgical Marie Lannelongue</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Clinique Pasteur Toulouse</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hopital Louis Pradel</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>HÃ´pital Necker-Enfants Malades</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Paris Cardiovascular Research Center (Inserm U970)</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Severe pulmonary regurgitation is common in patients with Tetralogy of Fallot and results in
      progressive right ventricular dilatation and dysfunction. Pulmonary valve replacement is
      frequent in this population, and percutaneous procedures are increasing.

      Ventricular arrhythmias are a frequent late complication in patients with tetralogy of
      Fallot. The most common critical isthmus of ventricular tachycardias is between the pulmonary
      valve and the ventricular septal defect patch.

      While an electrophysiology study is sometimes performed in expert centers before surgical
      pulmonary valve replacement to guide a surgical ablation if needed, this approach is not
      recommended in current guidelines. An electrophysiology study should also be considered
      before percutaneous pulmonary valve replacement, as a part of the critical isthmus may be
      covered by the prosthetic pulmonary valve. Moreover, ablation after percutaneous pulmonary
      valve insertion exposes patients to the risks of traumatic valve or stent injury and
      infectious endocarditis.

      At present, reliable predictors to identify high-risk patients in whom an electrophysiology
      study should be performed before pulmonary valve replacement are lacking.

      The aim of this study is to assess prospectively the yield of systematic electrophysiology
      study and programmed ventricular stimulation before surgical and percutaneous pulmonary valve
      replacement in patients with tetralogy of Fallot.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Positive programmed ventricular stimulation defined as inducibility of sustained ventricular tachycardia or fibrillation</measure>
    <time_frame>During ventricular programmed stimulation</time_frame>
    <description>Rate of sustained monomorphic or polymorphic ventricular tachycardia or ventricular fibrillation sustained &gt; 30 secondes during programmed ventricular stimulation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Critical isthmus involved in ventricular tachycardias induced</measure>
    <time_frame>During ventricular programmed stimulation</time_frame>
    <description>Description of different critical isthmus involved in ventricular tachycardias induced. Electrophysiological characteristics will be analyzed (conduction velocity, voltage, fragmentation, lenght, width).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications associated with programmed ventricular stimulation</measure>
    <time_frame>1 month</time_frame>
    <description>Complications considered:
death
vascular complications
pericardial effusion
stroke
atrioventricular block
heart failure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of ventricular arrhythmias during the follow-up after pulmonary valve replacement</measure>
    <time_frame>24 months</time_frame>
    <description>Sustained ventricular tachycardias or ventricular fibrillations &gt; 30 secondes and sudden cardiac deaths will be considered</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Congenital Heart Disease</condition>
  <condition>Fallot Tetralogy</condition>
  <condition>Ventricular Arrythmia</condition>
  <condition>Pulmonary Valve Regurgitation</condition>
  <arm_group>
    <arm_group_label>Programmed ventricular stimulation before PVR</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Programmed ventricular stimulation</intervention_name>
    <description>Programmed ventricular stimulation before pulmonary valve replacement. Voltage and activation mapping of right ventricle in a subset of patients.</description>
    <arm_group_label>Programmed ventricular stimulation before PVR</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients with repaired tetralogy of Fallot referred for surgical or percutaneous
        pulmonary valve replacement
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients with repaired tetralogy of Fallot referred for surgical or percutaneous
             pulmonary valve replacement

        Exclusion Criteria:

          -  Absence of patient's consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Victor Waldmann, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>European Georges Pompidou Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Victor Waldmann, MD, MPH</last_name>
    <phone>+33676098007</phone>
    <email>victor.waldmann@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Wided Msakni, MS</last_name>
    <phone>+33156093656</phone>
    <email>wided.msakni@aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Paris Cardiovascular Research Center</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Victor Waldmann, MD, MPH</last_name>
      <phone>+33676098007</phone>
      <email>victor.waldmann@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Wided Msakni, MS</last_name>
      <phone>+33156093656</phone>
      <email>wided.msakni@aphp.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Victor Waldmann, MD, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nicolas Combes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Francis Bessiere, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>December 15, 2019</study_first_submitted>
  <study_first_submitted_qc>December 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 19, 2019</study_first_posted>
  <last_update_submitted>March 2, 2020</last_update_submitted>
  <last_update_submitted_qc>March 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>programmed ventricular stimulation</keyword>
  <keyword>catheter ablation</keyword>
  <keyword>electrophysiology study</keyword>
  <keyword>tetralogy of Fallot</keyword>
  <keyword>pulmonary valve replacement</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Tetralogy of Fallot</mesh_term>
    <mesh_term>Pulmonary Valve Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

